Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:liraglutide
go back to main search page
Accession:XCO:0000907 term browser browse the term
Definition:Any condition in which the main influencing factor is liraglutide, a lipopeptide that is an analogue of human GLP-1 and an agonist of the GLP-1 receptor. Liraglutide is used as a hypoglycemic agent and supplemental therapy in the treatment of diabetes mellitus.
Synonyms:exact_synonym: NN-2211;   Saxenda;   Victoza
 xref: PMID:29976929



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    chemical 707
      chemical with specified function 434
        hypoglycemic agent 0
          liraglutide 0
Path 2
Term Annotations click to browse term
  experimental condition 2376
    chemical 707
      chemical with specified function 434
        activator 1
          receptor agonist 1
            liraglutide 0
paths to the root